Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Broadcom
AVGO
|
+$910M |
| 3 |
Amazon
AMZN
|
+$833M |
| 4 |
Tesla
TSLA
|
+$824M |
| 5 |
Workday
WDAY
|
+$753M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$6.93B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$969M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$586M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$476M |
| 5 |
Palo Alto Networks
PANW
|
+$473M |
Sector Composition
| 1 | Technology | 20.46% |
| 2 | Consumer Discretionary | 10.44% |
| 3 | Healthcare | 5.61% |
| 4 | Communication Services | 5.39% |
| 5 | Financials | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5226
Senseonics Holdings
SENS
$375M
| $82.9K | ﹤0.01% |
145,357
-36,914
| -20% | -$21K |
|
5227
Telefonica
TEF
$30.3B
| $82.8K | ﹤0.01% |
21,232
-911,976
| -98% | -$3.56M |
|
5228
Eton Pharmaceutcials
ETON
$473M
| $80.7K | ﹤0.01% |
18,428
-46,782
| -72% | -$205K |
|
5229
Biodesix
BDSX
$55M
| $80.6K | ﹤0.01% |
43,801
+16,975
| +63% | +$31.2K |
|
|
PAYOW
5230
DELISTED
Payoneer Global Inc. Warrant
PAYOW
| $80.3K | ﹤0.01% |
233,938
+935
| +0.4% | +$321 |
|
5231
DHI Group
DHX
$141M
| $80K | ﹤0.01% |
30,883
-10,727
| -26% | -$27.8K |
|
|
EOD
5232
Allspring Global Dividend Opportunity Fund
EOD
$245M
| $79.4K | ﹤0.01% |
+18,297
| New | +$79.4K |
|
|
OPTN
5233
DELISTED
OptiNose
OPTN
| $78.9K | ﹤0.01% |
+4,077
| New | +$78.9K |
|
|
GAN
5234
DELISTED
GAN Ltd
GAN
| $78.8K | ﹤0.01% |
49,886
+37,388
| +299% | +$59.1K |
|
5235
Biote Corp
BTMD
$107M
| $78.6K | ﹤0.01% |
15,910
+3,065
| +24% | +$15.1K |
|
5236
Nektar Therapeutics
NKTR
$926M
| $78.1K | ﹤0.01% |
9,210
+7,799
| +553% | +$66.1K |
|
|
ZTR
5237
Virtus Total Return Fund
ZTR
$349M
| $77.5K | ﹤0.01% |
14,061
+3,483
| +33% | +$19.2K |
|
|
ADAP
5238
Adaptimmune Therapeutics
ADAP
$14.8M
| $77.4K | ﹤0.01% |
+97,580
| New | +$77.4K |
|
5239
PodcastOne
PODC
$48.1M
| $76.6K | ﹤0.01% |
+41,387
| New | +$76.6K |
|
5240
PepGen
PEPG
$48.5M
| $76.4K | ﹤0.01% |
+11,228
| New | +$76.4K |
|
|
FCO
5241
abrdn Global Income Fund
FCO
$46.8M
| $76.2K | ﹤0.01% |
+11,801
| New | +$76.2K |
|
5242
Cambium Networks
CMBM
$20.4M
| $76K | ﹤0.01% |
+12,671
| New | +$76K |
|
5243
Sangamo Therapeutics
SGMO
$152M
| $75K | ﹤0.01% |
+138,038
| New | +$75K |
|
5244
Verrica Pharmaceuticals
VRCA
$44.9M
| $74.9K | ﹤0.01% |
+1,023
| New | +$74.9K |
|
5245
Taysha Gene Therapies
TSHA
$837M
| $74.8K | ﹤0.01% |
+42,278
| New | +$74.8K |
|
5246
Citius Pharmaceuticals
CTXR
$20.6M
| $74.7K | ﹤0.01% |
+3,948
| New | +$74.7K |
|
5247
Rigel Pharmaceuticals
RIGL
$681M
| $73.6K | ﹤0.01% |
5,077
+2,671
| +111% | +$38.7K |
|
5248
Apyx Medical
APYX
$79.4M
| $73.5K | ﹤0.01% |
+28,050
| New | +$73.5K |
|
5249
Finance of America Companies
FOA
$278M
| $71.7K | ﹤0.01% |
6,514
+4,485
| +221% | +$49.3K |
|
|
DZSI
5250
DELISTED
DZS Inc. Common Stock
DZSI
| $70.4K | ﹤0.01% |
35,737
-114
| -0.3% | -$225 |
|